Parents with children under the age of five who are still not eligible for a COVID-19 vaccine have been waiting for vaccine approval for this youngest population. And some are frustrated that their kids are missing out on important developmental milestones due to the continued isolation.
And, said Nick Giglia, a father of two from Montclair, “It feels like the whole world has moved on without us. And everybody is eager for COVID to be over. Nobody is more eager than we are, but unfortunately, it’s not over. Cases have been spiking for the last several weeks. And our kids literally have no protection.”
Moderna asked the Food and Drug Administration for emergency use authorization for its two-dose vaccine regimen for children under six in April. This week, Pfizer released data saying its three-dose regimen was safe and effective for kids under five. The FDA has scheduled a meeting for June 15 to review both vaccines, but there are still several hurdles to be jumped before those shots become available.
